Search

Search Results
Results 261 - 270 of 603 for Skin Cancer
  • Mylotarg
    Drug - 11 Jan 2022
    Consumer Medicine Information (CMI) about Mylotarg (Gemtuzumab ozogamicin) intended for persons living in Australia.
  • Lorviqua
    Drug - 23 Dec 2021
    Consumer Medicine Information (CMI) about Lorviqua intended for persons living in Australia.
  • Flomaxtra
    Drug - 22 Jul 2021
    Consumer Medicine Information (CMI) about Flomaxtra intended for persons living in Australia.
  • Rasagiline-Teva
    Drug - 10 Jun 2021
    Consumer Medicine Information (CMI) about Rasagiline-Teva intended for persons living in Australia.
  • Azilect
    Drug - 10 Jun 2021
    Consumer Medicine Information (CMI) about Azilect intended for persons living in Australia.
  • Norinyl-1
    Drug - 16 Mar 2020
    Consumer Medicine Information (CMI) about Norinyl-1 (Mestranol and Norethisterone) intended for persons living in Australia.
  • DBL Dexamethasone Sodium Phosphate
    Drug - 11 Aug 2025
    Consumer Medicine Information (CMI) about DBL Dexamethasone Sodium Phosphate (Dexamethasone Phosphate) intended for persons living in Australia.
  • Fragmin
    Drug - 10 Jul 2025
    Consumer Medicine Information (CMI) about Fragmin (Dalteparin sodium) intended for persons living in Australia.
  • Pacrolim
    Drug - 12 Aug 2024
    Consumer Medicine Information (CMI) about Pacrolim (Tacrolimus) intended for persons living in Australia.
  • Piax Plus Asprin
    Drug - 3 Apr 2024
    Consumer Medicine Information (CMI) about Piax Plus Asprin (clopidogrel hydrogen sulfate and aspirin) intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback